Long-term cardiovascular outcomes after mini-crush or T and minimal protrusion techniques in complex bifurcation lesions: the EVOLUTE-CRUSH III study

• Published in: Coronary artery disease Vol. 35; no. 8; pp. 641 - 649
• Main Authors: Güner, Ahmet, Uzun, Fatih, Çizgici, Ahmet Yaşar, Kahraman, Serkan, Demirci, Gökhan, Çiloğlu, Koray, Gökçe, Kaan, Doğan, Abdullah, Akman, Cemalettin, Uysal, Hande, Gültekin Güner, Ezgi, Aktürk, İbrahim Faruk, Yildiz, Mustafa, Serter, Berkay, Yalçin, Ahmet Arif, Keskin, Berhan, Ertürk, Mehmet
• Format: Journal Article
• Language: English
• Published: England 01-12-2024
• Subjects: Aged; Coronary Angiography - methods; Coronary Artery Disease - therapy; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction - epidemiology; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - instrumentation; Percutaneous Coronary Intervention - methods; Retrospective Studies; Stents; Time Factors; Treatment Outcome
• ISSN: 0954-6928; 1473-5830; 1473-5830
• DOI: 10.1097/MCA.0000000000001392

Mini-crush (MC) and T-stenting and small protrusion (TAP) techniques are frequently used, but the long-term comparison of both techniques in patients with complex bifurcation lesions (CBLs) is still a debatable issue. This study sought to retrospectively evaluate the long-term outcomes of MC and TAP techniques in patients with CBLs.
A total of 271 patients [male: 202 (78.9%), mean age: 58.90 ± 10.11 years] patients in whom complex bifurcation intervention was performed between 2014 and 2023 were involved. The primary endpoint was major cardiovascular events (MACE) as the combination of cardiac death, target vessel myocardial infarction, or clinically driven-target lesion revascularization. The Cox proportional hazard models were adjusted by the inverse probability weighting approach to reduce treatment selection bias.
The initial management strategy was MC in 146 patients and TAP in 125 cases. MACE occurred in 52 patients (19.2%) during a mean follow-up period of 32.43 ± 16 months. The incidence of MACE (13 vs. 26.4%, P  = 0.005) and major cardiovascular and cerebral events (15.1 vs. 28.8%, P  = 0.006) were significantly lower in the MC group than in the TAP group. Additionally, the incidence of definite or probable stent thrombosis was numerically lower in the MC group compared with the TAP group but did not differ significantly (2.7 vs. 8%, P  = 0.059). The long-term MACE was notably higher in the TAP group than the MC group [adjusted hazard ratio (inverse probability weighted): 1.936 (95% confidence interval: 1.053-3.561), P  = 0.033].
In this study involving patients with CBLs, percutaneous coronary intervention with the MC technique had better long-term outcomes than the TAP technique.